Specifically, there are several ribonucleosides analogues, originally developed for antiviral therapy, which are substrates and inhibitors of human mitochondrial RNA polymerase (POLRMT) [33], and can be repurposed for cancer therapy. The gene discussed is POLRMT; the disease is cancer.